Posts by: Daniela Semedo, PhD

Daniela Semedo, PhD

Daniela holds a PhD in Clinical Psychology from The University of Edinburgh, United Kingdom, a MSc in Health Psychology and a BSc in Clinical Psychology. Her work has been focused on vulnerability to psychopathology and early identification and intervention in psychosis.

October 4, 2016

Common BP Drug May Prevent Resistance to Tarceva in NSCLC Patients

News

A blood pressure-lowering drug called Edecrin (ethacrynic acid) may be used to prevent resistance to the lung cancer agent Tarceva (erlotinib), scientists from Imperial College London and Fudan University ... Read more

April 19, 2016April 20, 2016

Genentech’s Atezolizumab for Advanced Non-small Cell Lung Cancer Granted FDA Priority Review

News

The U.S. Food and Drug Administration (FDA) has accepted Genentech’s Biologics License Application (BLA) and granted Priority Review status for atezolizumab for patients with locally advanced or metastatic non-small ... Read more

December 14, 2015December 14, 2015

NSCLC Phase 3 Trial of Fruquintinib Opening in China

News

The global healthcare company Hutchison China MediTech Limited (Chi-Med), has announced that its R&D subsidiary Hutchison MediPharma Limited (HMP) is beginning FALUCA, a Phase 3 registration clinical trial of fruquintinib (HMPL-013) ... Read more

December 2, 2015December 2, 2015

Subsolid Lung Nodules Pose Greater Cancer Risk to Women than Men

News

Women with a specific form of lung nodule evident in lung cancer screening CT tests are at increased risk of lung cancer compared to men with identical lung nodules. These were ... Read more

November 11, 2015November 11, 2015

Intensity Modulated Radiation Therapy In Non-Small Cell Lung Cancer Treatment Associated With Less Side Effects

News

Results from a worldwide collaborative clinical trial in patients with locally advanced non-small cell lung cancer (NSCLC) revealed that those treated with intensity modulated radiation therapy (IMRT) had lower serious lung toxicity ... Read more

September 17, 2015September 17, 2015

Smoking As A Predictor Of Lung Cancer Recurrence

News

In the United States 158,040 people are expected to die in 2015 from lung cancer, making this disease a principal cause of death. Recently, low-dose CT scans for lung cancer screening in ... Read more

June 23, 2015June 24, 2015

Accurate New Biomarker For NSCLC Detection

News

In a recent study published in the journal Oncotarget, a team of researchers from the The Wistar Institute have discovered a blood-circulating protein that is more accurate in detecting non-small cell ... Read more

June 17, 2015June 19, 2015

Moffitt Researchers Present Data On MEDI4736 Combined With Tremelimumab For NSCLC Patients

News

During the 2015 Annual Meeting of the American Society of Clinical Oncology, Chicago, Scott J. Antonia, M.D., Ph.D., chair of the Thoracic Oncology Department at Moffitt Cancer Center presented the ... Read more

May 11, 2015May 11, 2015

Link Between Inherited Genetic Variations and Outcomes of Non-Small Cell Lung Cancer Uncovered

Lung cancer News, News

Results from a recent study conducted by a team of researchers at the Moffitt Cancer Center found that hereditary genetic variations in interleukin genes are related with survival improvement ... Read more

May 1, 2015May 1, 2015

Proton Radiotherapy Feasible To Target Lung Cancer

News

During the 3rd ESTRO Forum that took place in Barcelona last week, researchers presented a new breathing movement model that allows the exact measurement of narrow beams directed towards a tumor model by simulating ... Read more